ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 292 filers reported holding ICU MED INC in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,391,376 | -22.6% | 188,147 | +15.9% | 0.00% | -33.3% |
| Q2 2023 | $28,918,813 | -2.6% | 162,292 | -9.8% | 0.00% | 0.0% |
| Q1 2023 | $29,677,293 | +25.3% | 179,906 | +19.7% | 0.00% | 0.0% |
| Q4 2022 | $23,677,276 | -6.5% | 150,351 | -10.6% | 0.00% | 0.0% |
| Q3 2022 | $25,327,000 | -8.9% | 168,178 | -0.5% | 0.00% | 0.0% |
| Q2 2022 | $27,793,000 | -17.4% | 169,067 | +11.8% | 0.00% | 0.0% |
| Q1 2022 | $33,661,000 | +6.3% | 151,188 | +13.3% | 0.00% | 0.0% |
| Q4 2021 | $31,661,000 | -5.5% | 133,400 | -7.1% | 0.00% | 0.0% |
| Q3 2021 | $33,511,000 | +9.2% | 143,593 | -3.7% | 0.00% | 0.0% |
| Q2 2021 | $30,694,000 | +3.7% | 149,148 | +3.6% | 0.00% | 0.0% |
| Q1 2021 | $29,589,000 | +10.2% | 144,028 | +15.0% | 0.00% | 0.0% |
| Q4 2020 | $26,857,000 | +3.9% | 125,219 | -11.4% | 0.00% | -25.0% |
| Q3 2020 | $25,842,000 | +83.7% | 141,389 | +85.2% | 0.00% | +100.0% |
| Q2 2020 | $14,071,000 | -5.1% | 76,343 | +3.9% | 0.00% | -33.3% |
| Q1 2020 | $14,825,000 | +22.2% | 73,475 | +13.3% | 0.00% | +50.0% |
| Q4 2019 | $12,130,000 | -3.6% | 64,825 | -17.8% | 0.00% | 0.0% |
| Q3 2019 | $12,586,000 | -28.9% | 78,861 | +12.2% | 0.00% | -33.3% |
| Q2 2019 | $17,700,000 | +7.7% | 70,263 | +2.3% | 0.00% | 0.0% |
| Q1 2019 | $16,433,000 | +15.8% | 68,663 | +11.1% | 0.00% | +50.0% |
| Q4 2018 | $14,188,000 | -47.6% | 61,786 | -35.5% | 0.00% | -50.0% |
| Q3 2018 | $27,088,000 | -10.4% | 95,797 | -6.9% | 0.00% | -20.0% |
| Q2 2018 | $30,224,000 | +7.9% | 102,926 | -7.2% | 0.01% | 0.0% |
| Q1 2018 | $28,003,000 | -17.4% | 110,947 | -29.3% | 0.01% | -16.7% |
| Q4 2017 | $33,909,000 | -25.8% | 156,983 | -36.2% | 0.01% | -14.3% |
| Q3 2017 | $45,700,000 | +54.0% | 245,902 | +43.0% | 0.01% | +16.7% |
| Q2 2017 | $29,667,000 | +98.1% | 171,980 | +75.4% | 0.01% | +100.0% |
| Q1 2017 | $14,974,000 | +40.5% | 98,059 | +35.6% | 0.00% | +50.0% |
| Q4 2016 | $10,657,000 | +77.2% | 72,319 | +52.0% | 0.00% | +100.0% |
| Q3 2016 | $6,013,000 | +26.0% | 47,588 | +12.4% | 0.00% | 0.0% |
| Q2 2016 | $4,772,000 | -11.0% | 42,325 | -17.8% | 0.00% | 0.0% |
| Q1 2016 | $5,362,000 | +32.8% | 51,510 | +43.9% | 0.00% | 0.0% |
| Q4 2015 | $4,037,000 | -35.3% | 35,799 | -37.2% | 0.00% | -50.0% |
| Q3 2015 | $6,238,000 | +40.6% | 56,967 | +22.8% | 0.00% | +100.0% |
| Q2 2015 | $4,437,000 | +65.9% | 46,387 | +61.6% | 0.00% | 0.0% |
| Q1 2015 | $2,674,000 | +34.1% | 28,712 | +17.9% | 0.00% | 0.0% |
| Q4 2014 | $1,994,000 | +64.7% | 24,357 | +29.0% | 0.00% | – |
| Q3 2014 | $1,211,000 | +1.3% | 18,878 | -3.9% | 0.00% | – |
| Q2 2014 | $1,195,000 | +23.7% | 19,647 | +21.8% | 0.00% | – |
| Q1 2014 | $966,000 | -48.1% | 16,129 | -44.9% | 0.00% | -100.0% |
| Q4 2013 | $1,863,000 | -9.5% | 29,253 | -3.5% | 0.00% | 0.0% |
| Q3 2013 | $2,058,000 | +18.5% | 30,301 | +25.8% | 0.00% | 0.0% |
| Q2 2013 | $1,736,000 | – | 24,087 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |